Umer Raffat

Selected news for the person - Umer Raffat, collected since 2/2018. Recent stories appear in Yahoo News. This person shares healthcare news with Gilead, Biogen, Gilead Sciences, COVID-19 and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
5/11/2021 Mirati Therapeutics (MRTX) Received its Third Buy in a Row markets.co Mirati Therapeutics (MRTX) Received its Third Buy in a Row Brian Anderson - May 11, 2021, 5:46 AM EDT SHARE ON:After H.C. Wainwright and J.P. Morgan gave Mirati Therapeutics (NASDAQ: MRTX ) a Buy rating last month, the company received another Buy, this time from Evercore ISI. Analyst Umer Raffat maintained a Buy rating on Mirati Therapeutics yesterday. $147.63. Raffat is a 2-star analyst with an average return of 1.0 ...
5/6/2021 Asian Vaccine Makers’ Shares Slammed as U.S. Backs IP Waiver Yahoo News ... announcement. The Biden administration’s plans will only open up a negotiation at the WTO and other countries and members remain unwilling, said Barclays analyst Carter Gould in a note.For Evercore ISI analyst Umer Raffat , U.S. support didn’t mean it was a “100% done deal” as other countries are also opposed. It “remains to be seen if U.S. leadership’s position sways others,” Raffat wrote in ...
5/6/2021 Asian Vaccine Makers’ Shares Slammed as U.S. Backs IP Waiver Yahoo News ... announcement. The Biden administration’s plans will only open up a negotiation at the WTO and other countries and members remain unwilling, said Barclays analyst Carter Gould in a note.For Evercore ISI analyst Umer Raffat , U.S. support didn’t mean it was a “100% done deal” as other countries are also opposed. It “remains to be seen if U.S. leadership’s position sways others,” Raffat wrote in ...
4/29/2021 Evercore ISI Reaffirms Their Buy Rating on Amgen (AMGN) analystratings.com By Jason CarrIn a report released yesterday, Umer Raffat from Evercore ISI maintained a Buy rating on Amgen ( AMGN – Research Report ). $236.71. Raffat is a 2- 2.9% and a 51.1% success rate. Raffat covers the Healthcare Kodiak Sciences, Vor Biopharma, and Athenex.Amgen has an analyst consensus of Moderate Buy, with a price target consensus of $250.24, a 3.6% upside from current levels. In a report issued on ...
4/29/2021 Merck & Co., Inc. (MRK) Q1 2021 Earnings Call Transcript alphastreet.com ... President and President, Human Health Caroline Litchfield — Executive Vice President and Chief Financial Officer Dean Y. Li — Executive Vice President and President, Merck Research Laboratories Terence Flynn — Goldman Sachs — Analyst Umer Raffat — Evercore ISI — Analyst Chris Schott — J.P. Morgan — Analyst Andrew Baum — Citigroup — Analyst Geoff Meacham — Bank of America — Analyst Ronny Gal — Bernstein — Analyst Luisa Hector ...
4/28/2021 Amgen Inc. (AMGN) Q1 2021 Earnings Call Transcript alphastreet.com ... Michael Yee — Jefferies — Analyst Jay Olson — Oppenheimer — Analyst Matthew Harrison — Morgan Stanley — Analyst Yaron Werber — Cowen and Company — Analyst Terence Flynn — Goldman Sachs — Analyst Umer Raffat — Evercore ISI — Analyst Mohit Bansal — Citi — Analyst Geoffrey Porges — SVB Leerink — Analyst Alethia Young — Cantor Fitzgerald — Analyst Dane Leone — Raymond James — Analyst Ronny Gal ...
4/27/2021 Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript alphastreet.com ... Research — Analyst Andrew Baum — Citigroup — Analyst Steve Scala — Cowen — Analyst Terence Flynn — Goldman Sachs — Analyst Ronny Gal — Bernstein — Analyst Kerry Holford — Berenberg — Analyst Umer Raffat — Evercore — Analyst Gregg Gilbert — Truist Securities — Analyst Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q1 2021 Earnings Conference Call. [Operator Instructions] As a ...
4/22/2021 Biogen Inc. (BIIB) Q1 2021 Earnings Call Transcript alphastreet.com ... and Development Michael McDonnell — Chief Financial Officer Michael Yee — Jefferies — Analyst Ronny Gal — Bernstein — Analyst Marc Goodman — SVB Leerink — Analyst Yatin Suneja — Guggenheim Partners — Analyst Umer Raffat — Evercore — Analyst Matthew Harrison — Morgan Stanley — Analyst Brian Abrahams — RBC Capital Markets — Analyst Colin Bristow — UBS — Analyst Evan Seigerman — Credit Suisse — Analyst Jay Olson ...